Arthur Reine

Arthur Reine has extensive work experience in finance and leadership roles. Arthur is currently the Senior Director of Finance at GV20 Therapeutics since April 2022. Prior to this, they served as the Director of Finance, supporting Manufacturing and R&D at Kala Pharmaceuticals from February 2019 to April 2022. From May 2015 to January 2019, they were the Director of Finance at Cold Chain Technologies. Arthur worked at Harvard Bioscience Inc. as the VP Finance and Controller from May 1999 to May 2015. Before that, they held the role of Division Controller at Senior Flexonics Metal Bellows Division from September 1997 to May 1999. Arthur was also the Corporate Controller at Astro-Med, Inc. from May 1996 to September 1997. Arthur served as the CFO and Director of Operations at Brainstorm Technology from September 1995 to May 1996. Before that, they held the position of Director of Finance at ATI/Orion Research from 1988 to 1995. Arthur began their career as a Division Controller at Spectra-Physics from 1983 to 1988.

Arthur Reine earned their Bachelor of Science degree in Finance from the University of Maryland, where they attended from 1977 to 1981. Arthur continued their education at The Ohio State University, completing their Master of Business Administration (MBA) in Accounting and Finance from 1981 to 1983. In addition to their degrees, Arthur has obtained several certifications throughout their career, including the Certified in Financial Management (CFM) certification from IMA in 1995 and the Certified Management Accountant (CMA) certification in 1991. Arthur also obtained the Certified Cash Manager (CCM) certification from the Association of Financial Professionals in 1993. More recently, in 2017, Arthur earned the Certified Corporate Financial Planning and Analysis Professional certification from the Association for Financial Professionals.